Swine flu tally continues to climb
ATLANTA The Centers for Disease Control and Prevention Monday morning updated its tally of confirmed H1N1 flu cases, formerly known as the swine flu.
To date, there are 286 confirmed cases across 36 states in the United States, with one death in Texas.
The CDC also announced it had been scheduled to complete deployment of 25% of the supplies in the Strategic National Stockpile to all states in the continental United States.
“These supplies and medicines will help states and U.S. territories respond to the outbreak,” the CDC stated. “In addition, the federal government and manufacturers have begun the process of developing a vaccine against the novel H1N1 flu virus.”
The list of states with confirmed cases (with number of cases in parentheses) are: Alabama (4), Arizona (17), California (30), Colorado (7), Connecticut (2), Delaware (20), Florida (5), Idaho (1), Illinois (8), Indiana (3), Iowa (1), Kansas (2), Kentucky (1, though the patient is hospitalized in Georgia), Louisiana (14), Maryland (4), Massachusetts (6), Michigan (2), Minnesota (1), Missouri (1), Nebraska (1), Nevada (1), New Hampshire (1), New Jersey (7), New Mexico (1), New York (73), North Carolina (1), Ohio (3), Oregon (3), Pennsylvania (1), Rhode Island (1), South Carolina (15), Tennessee (1), Texas (41, with one confirmed death), Utah (1), Virginia (3) and Wisconsin (3).
HHS releases television, radio PSAs on swine flu
WASHINGTON The U.S. Department of Health and Human Services on Friday announced the availability of television and radio public service announcements on steps people can take against 2009 H1N1 influenza, also known as the swine flu.
The TV PSA, a 60-second spot featuring Acting Surgeon General Steven Galson, will be satellite fed 2 p.m. on Friday. The feed will be handled by the National Association of Broadcasters.
Three 30-second radio PSAs in English and another three in Spanish are available for download at a site hosted by the Centers for Disease Control and Prevention. The spots are in MP3 format and are accompanied by matching live-read scripts.
FDA warns consumers about Hydroxycut
ROCKVILLE, Md. The Food and Drug Administration on Friday warned consumers to immediately stop using Hydroxycut products by Iovate Health Sciences based on a possible association with a number of serious liver injuries.
Iovate has agreed to recall Hydroxycut products from the market.
“Iovate Health Sciences is strongly committed to product safety and welcomes balanced regulation for the dietary supplement industry,” the company stated Friday. “The number of adverse event reports described by the FDA in its advisory is small relative to the many millions of people who have used Hydroxycut products over the past seven years. Iovate’s own assessment of the potential risk associated with the use of these products differs from that expressed by the FDA. Every product marketed by Iovate is evaluated during its development for the safety of its individual ingredients,” the company noted.
Steve Mister, president and CEO for the Council for Responsible Nutrition, stated that, “both the Food and Drug Administration, as well as the manufacturer of the Hydroxycut products in question, took appropriate action today. We commend FDA for warning consumers of a potential safety problem associated with these products, and were encouraged to see that the company — Iovate Health Sciences — agreed to recall the products from the market until further determinations can be made.”
Hydroxycut is the leading dietary supplement diet aid in food, drug and mass markets, generating $36.8 million in sales across food, drug and mass (minus Walmart) outlets for the 52 weeks ended Oct. 5, 2008, according to Information Resources Inc. data. According to FDA officials, Hydroxycut reported it had sold more than 9 million units in the calendar year of 2008.
“The FDA urges consumers to discontinue use of Hydroxycut products in order to avoid any undue risk,” stated Linda Katz, interim chief medical officer of the FDA’s Center for Food Safety and Applied Nutrition. During a press conference with reporters Friday morning, the identification of the possible link between liver adverse events and Hydroxycut was made possible in part by the mandatory reporting of adverse events associated with dietary supplements.
The FDA has received 23 reports of serious health problems, ranging from jaundice and elevated liver enzymes, an indicator of potential liver injury, to liver damage requiring liver transplant. One death due to liver failure has been reported to the FDA. Other health problems reported include seizures; cardiovascular disorders; and rhabdomyolysis, a type of muscle damage that can lead to other serious health problems such as kidney failure.
The death occurred in the fall of 2007 and was reported to the agency in March, 2009, FDA stated. “[However], the 2007 death referenced by the FDA was not caused by Hydroxycut,” the company noted.
Liver injury, although rare, was reported by patients at the doses of Hydroxycut recommended on the bottle. Symptoms of liver injury include jaundice (yellowing of the skin or whites of the eyes) and brown urine. Other symptoms include nausea, vomiting, light-colored stools, excessive fatigue, weakness, stomach or abdominal pain, itching and loss of appetite.
Hydroxycut products are dietary supplements that are marketed for weight-loss, as fat burners, as energy-enhancers, as low carb diet aids and for water loss under the Iovate and MuscleTech brand names. The list of products being recalled by Iovate currently includes:
- Hydroxycut Regular Rapid Release Caplets
- Hydroxycut Caffeine-Free Rapid Release Caplets
- Hydroxycut Hardcore Liquid Caplets
- Hydroxycut Max Liquid Caplets
- Hydroxycut Regular Drink Packets
- Hydroxycut Caffeine-Free Drink Packets
- Hydroxycut Hardcore Drink Packets (Ignition Stix)
- Hydroxycut Max Drink Packets
- Hydroxycut Liquid Shots
- Hydroxycut Hardcore RTDs (Ready-to-Drink)
- Hydroxycut Max Aqua Shed
- Hydroxycut 24
- Hydroxycut Carb Control
- Hydroxycut Natural
Although the FDA has not received reports of serious liver-related adverse reactions for all Hydroxycut products, Iovate has agreed to recall all the products listed above. Hydroxycut Cleanse and Hoodia products are not affected by the recall.